The Krebs (or tricarboxylic acid (TCA)) cycle has a central role in the regulation of brain energy regulation and metabolism, yet brain TCA cycle intermediates have never been directly detected in vivo. This study reports the first direct in vivo observation of a TCA cycle intermediate in intact brain, namely, 2-oxoglutarate, a key biomolecule connecting metabolism to neuronal activity. Our observation reveals important information about in vivo biochemical processes hitherto considered undetectable. In particular, it provides direct evidence that transport across the inner mitochondria membrane is rate limiting in the brain. The hyperpolarized magnetic resonance protocol designed for this study opens the way to direct and real-time studies of TCA cycle kinetics.
INTRODUCTION
The connection between cerebral energy metabolism and neural function was highlighted more than a century ago. 1 Following Krebs' formulation, it became well established that the tricarboxylic acid (TCA) cycle is central to brain energy homeostasis, 2 as it is the final common path for aerobic oxidation of any molecule that can be transformed into an acetyl group (carbohydrates, fatty acids, and amino acids). In addition, the cycle serves as a source of biosynthetic precursors for synthesis of physiological amino acids. Several crucial questions are, however, left unanswered, in particular the regulation of the metabolism of glutamate (Glu), the major excitatory neurotransmitter. Glutamate is in dynamic exchange with the TCA cycle intermediate 2-oxoglutarate (2OG; IUPAC nomenclature for a-ketoglutarate) through reactions that are key to the regulation of cellular oxygen metabolism such as the malate-aspartate shuttle, aspartate aminotransferase (AAT), and glutamate dehydrogenase. A difficulty in addressing the regulation of TCA cycle activity in vivo is rooted in the fact that the concentrations of TCA cycle intermediates are too small to be detectable using established in vivo methods such as magnetic resonance (MR). 3 To date, TCA cycle activity in vivo has been exclusively studied using carbon-13 ( 13 C) magnetic resonance spectroscopy (MRS), a technique that enables the investigation of metabolic processes in vivo in a non-invasive manner. 4 Because of the 13 C low natural abundance of B1%, this type of experiment requires the infusion of a suitable 13 C-labeled precursor, which leads to the distribution of the 13 C-label among the metabolic products and allows probing specific pathways. [5] [6] [7] The turnover of the label from precursors to products is typically measured from the time course of 13 C concentration changes readily quantifiable from the 13 C MR spectrum of the many available precursors. 13 C-labeled acetate has been used to investigate the TCA cycle rates using MRS. Acetate has the advantage of being readily taken up by the brain and as it is solely metabolized in astrocytes, it has been used as a tracer to study glial metabolism in vivo in rats [8] [9] [10] and in humans. 11 However, most of the molecules that become labeled as a consequence of the acetate infusion cannot be detected by MR in vivo because of their low concentration and the relatively low sensitivity of in vivo MR. Only the most concentrated amino acids, e.g., Glu, glutamine, and aspartate can be detected in vivo. [3] [4] [5] 12 These amino acids are not part of the TCA cycle but indirectly reflect TCA cycle activity because of label incorporation from TCA cycle intermediates, namely, 2OG and oxaloacetate.
The assumption required for determining TCA cycle flux through 13 C isotopomer analysis is that the relative concentration of 13 C isotopomers is identical in precursors and their detectable metabolic products. 13 In addition, dynamical analysis through this method is only representative of the TCA cycle kinetics if the exchange rate between TCA intermediates and products is at least on the same order of magnitude as the TCA cycle flux. Therefore, the direct detection of TCA cycle intermediates would provide new crucial information concerning the kinetics of the label flow through the TCA cycle.
MATERIALS AND METHODS

Dynamic Nuclear Polarization of 13 C-labeled Acetate
The 13 C nuclear spins in frozen glassy solutions of sodium [1-13 C]acetate or sodium [1,2-13 C 2 ]acetate (Sigma-Aldrich, Buchs, Switzerland) were dynamically polarized using a custom-designed DNP polarizer operating at 5 T and 1 ± 0.05 K as described in earlier publications. 14, 15 A 4.5 mol/L solution of sodium [1-13 C]acetate or sodium [1,2-13 C 2 ]acetate dissolved in a 2/1 (vol/vol) D 2 O/d 6 -ethanol (Cambridge Isotope Laboratories, Andover, MA, USA) containing 33 mmol/L of TEMPO nitroxyl radical (2,2,6,6tetramethyl-1-piperidinyloxy, Sigma-Aldrich) was prepared. Droplets of solution were plunged in liquid nitrogen to form frozen beads of B2 mm diameter. A volume of 0.4 ml of frozen solution was placed inside the DNP polarizer sample holder, which was then inserted into the microwave cavity located within the cryostat filled with B0.5 L of liquid helium at atmospheric pressure (4.2 K). The vacuum pump system was then turned on to lower the temperature of the sample space such as to maintain the frozen sample under superfluid helium at 1±0.05 K.
The microwave power at the output of the source was set to 40 mW and the irradiation frequency was set to 139.85 GHz. The nuclear polarization was monitored as a function of time by means of pulsed nuclear magnetic resonance using 51 tipping pulses. Once the polarization of the 13 C nuclei had reached a targeted value (the 13 C solid-state polarization reached 12±2% after 2±0.4 hours in sodium [1-13 C]acetate samples and after 1 ± 0.2 hours in sodium [1,2-13 C 2 ]acetate samples), the frozen solution was dissolved in 5 ml of superheated D 2 O (170 1C) by means of a dissolution apparatus similar to the one described by Ardenkjaer-Larsen et al. 16 In the system used for the present study, a helium gas stream drove the resulting solution out of the polarizer magnet through a 5-m long capillary into the bore of an animal imager, where the sample was collected in a remotely controlled infusion pump that separated the liquid solution from the gas, and infused a chosen amount of liquid solution into an animal. 14 Note that the solution contained a residual 2 mmol/L TEMPO radical, but its effect on acetate 13 C T 1 is negligible. 17 The delay between dissolution and infusion was set to 3 seconds.
Animal Preparation
All animal experiments were conducted according to federal and local ethical guidelines, and the protocols were approved by the local regulatory body of the Canton Vaud, Switzerland (Service de la consommation et des affaires vé té rinaires, Affaires vé té rinaires, Canton de Vaud, Suisse).
In vivo experiments were performed on male Sprague-Dawley rats (B450 g). Animals were anesthetized with 1.5% isoflurane in a 30% O 2 /70% N 2 O mixture. A femoral vein was catheterized for acetate infusion. The rat was placed on a holder along with the infusion pump and the femoral vein catheter was connected to the outlet of the pump. The holder was then inserted inside the scanner. A bolus of B2.2 ml of hyperpolarized solution containing B0.3 mol/L of the 13 C-labeled acetate was infused within 9 seconds. It contained a residual TEMPO concentration of B2 mmol/L and 2% of deuterated ethanol. Such concentrations should not affect cerebral metabolism within the time frame of our experiments. As mentioned by Sano et al, 18 most commercially available nitroxyl radicals are water-soluble and cannot pass through the blood-brain barrier. It was also showed in a recent in vivo 13 C MRS study that the cerebral metabolism observed after the infusion of [1-13 C]ethanol in rats at an B10-fold higher concentration than used in the present study is very similar to the metabolism observed after the injection of [1-13 C]acetate as a consequence of the conversion of ethanol to acetate in the liver and subsequent recirculation of acetate into the brain. 19 In our study, only B1% of the 13 C's come from residual ethanol. Rat physiology was monitored during the experiments: body temperature was kept between 37 1C and 38 1C while respiration rate was maintained at 60 per min by adjusting the isoflurane level in respiratory gases. The rate and dose of the infusion was determined in bench experiments to insure that the bolus-like infusion is not lethal for rats. The blood volume for a 450-g rat is B28 mL. 20 Taking into account that sodium concentration in the blood is B150 mmol/L, a bolus injection of 2.2 mL with a concentration of 300 mmol/L of sodium acetate will lead to a sodium plasma concentration of B160 mmol/L further attenuated during the time course by exchange with interstitial fluid. As the recorded physiological parameters (temperature, respiration rate as well as blood pH during the preparatory experiments) were stable throughout the experiments, we considered that this modest temporary increase in Na þ concentration had no influence on animal physiology. As shown by Lien et al, 21 no variations in brain metabolite concentrations such as Glu concentration were observed within 2 hours of acute hypernatremia (serum sodium 194 ± 5 mmol/L). We do not expect that any change can occur within a minute after the injection of the bolus. At the end of the experiment, animals were killed with an overdose of pentobarbital.
Magnetic Resonance Imaging and MRS Experiments
All measurements were performed on a Varian INOVA spectrometer (Varian, Palo Alto, CA, USA) interfaced to a 31-cm horizontal-bore actively shielded 9.4 T magnet (Magnex Scientific, Abingdon, UK). Radiofrequency (RF) transmission and reception was done using a home-built hybrid surface coil consisting of a proton quadrature coil and a three-loop 10-mm diameter carbon coil. This coil was placed on top of the rat head. The 13 C spectra were acquired through single-pulse experiments with 301 BIR-4 adiabatic radiofrequency pulses to compensate for B 1 inhomogeneities. 22 Localization was achieved using an outer volume suppression scheme 23 with voxels volume of 343 mL (7.3 Â 9.4 Â 5 mm 3 ). The time course measurements were acquired in a voxel of 275 mL (5 Â 5 Â 5 mm 3 ) using a series of 301 pulse applied every 3 seconds. The acquisition time was set to 200 ms. To generate an external reference signal, a small sphere filled with 99% 13 C-labeled formic acid was placed in the center of the carbon coil. High-order shimming was performed using the FASTESTMAP algorithm. 24 Data were processed using MATLAB. To perform homonuclear polarization transfer between the two 13 C spins of acetate, we used a specific pulse sequence consisting of a single-voxel localization scheme (7.3 Â 9.4 Â 5 mm 3 ) followed by three 901 radiofrequency pulses. 25 
RESULTS
Dissolution dynamic nuclear polarization (dissolution DNP), 16 a hyperpolarization technique based on low-temperature microwave-driven polarization transfer from the electron spins of paramagnetic centers to precursors nuclear spins 26 and providing an increase in MR sensitivity of up to four orders of magnitude, was implemented as follows: low-temperature DNP was performed in superfluid helium at 1±0.05 K using a home-built 5 T polarizer coupled to a 9.4-T animal scanner 14, 15 and, 3 seconds after dissolution, 13 C-labeled hyperpolarized acetate ( 13 C polarization of 12 ± 2%) was injected in the rats femoral vein before MRS measurements. The hyperpolarized 13 C signal was detectable over a time period on the order of the characteristic time T 1 required for the spin magnetization to return to its thermal equilibrium value. The in vivo 13 C characteristic signal decay time after bolus injection of the hyperpolarized [1-13 C]acetate solution was deduced by fitting the signal amplitude (corrected for the effect of the radiofrequency pulses) with a decaying monoexponential function and was determined to be 15±2 seconds in the rat head (n ¼ 4; data not shown).
To selectively measure the 13 C signal from the brain, a localization pulse sequence was used in conjunction with a surface coil. 23 A 13 C spectrum observed in the brain 16 seconds after dissolution ( Figures 1A and 1B ) delineates two peaks separated by 0.15 p.p.m., which were detected in all animals (n ¼ 3). The more intense signal (182.2 p.p.m.) was unambiguously assigned to the carboxyl 13 C of the injected acetate molecule. 27 The less intense resonance at 182.05 p.p.m. likely originated from a metabolic product of acetate. The chemical shift of 182.05 p.p.m. is within 8 Hz of the reported in vitro value of the 5-13 C resonance of [5-13 C]2OG. 27 Observing the incorporation of [1-13 C]acetate into [5-13 C]2OG should imply, considering the well-established metabolic pathways of acetyl-CoA metabolism in the TCA cycle, that the creation of [4,5-13 C 2 ]2OG from [1,2-13 C 2 ]acetyl-CoA is detectable. Therefore, a second set of experiments (n ¼ 3) was performed under identical conditions, except that [1,2-13 C 2 ]acetate was infused. The interaction between the two adjacent 13 C nuclear spins through their chemical bonds leads to a splitting of their resonance peak into two lines (J-coupling) that are separated according to the strength of the interaction. The spectra presented in Figures 2A and 2C show that the acetyl moiety is indeed incorporated into the observed metabolite, as its resonance is split into two lines separated by a frequency corresponding to 13 C-13 C J-coupling, as is the case for the precursor acetate resonance. This result implies that the acetyl moiety remained intact through the metabolic processes leading to its incorporation into the observed metabolite.
To provide even further evidence for the metabolite assignment, a custom-tailored adiabatic polarization transfer sequence was developed and designed for this particular study. 25 Before detection, the enhanced carboxyl 13 C polarization was transferred to the aliphatic 13 C spins, which exhibit large chemical shift dispersion. Although both the carboxyl and the aliphatic 13 C polarizations are enhanced through DNP, the aliphatic 13 C will not remain hyperpolarized in vivo because of its short T 1 relaxation time on the order of 2 seconds. This was verified in three experiments, in which no [2-13 C]acetate signal was observable before polarization transfer. To ensure that the same stage of the metabolic process was probed, the time interval between dissolution and data acquisition was set as in the previous measurement to 16 seconds. The spectra recorded in the aliphatic region after the polarization transfer are presented in Figures 2B and 2D . The two resonances observed were assigned to acetate (24.5 p.p.m.) and 2OG (36.0 p.p.m.), which is consistent with the carboxyl spectra (Figures 2A and 2C ). From the results described above, we conclude that the metabolite observed in the brain after the injection of hyperpolarized acetate is indeed 2OG. The time evolution of the acetate and 2OG signal integrals (data measured on four different animals) is presented in Figure 3 . We observed that the maximum signal of 2OG is delayed by 2±0.5 seconds as compared with the maximum signal of acetate. Note that the small ratio between acetate and 2OG signals (2.2 ± 0.3) suggests that the concentration of [1-13 C]acetate inside the brain is low at the time of the measurements.
DISCUSSION
To the best of our knowledge, this is the first time 2OG is directly observed in vivo in brain. We are not aware of any report describing the detection of 2OG using non-hyperpolarized MR including our own attempts, which implies either an upper concentration limit on the order of 0.1 mmol/g (MR detection limit) or that the intermediate is predominantly in a bound state characterized by a broad and thus unobservable MR signal. Indeed, based on recent structural investigations noting a close colocalization of the TCA cycle enzymes, the proposal has emerged that some, if not all, TCA cycle enzymes may operate in vivo as a single unit (metabolon). [28] [29] [30] The present study shows that at least a sizable portion of 2OG (an estimation is given below) is sufficiently mobile to be detected by dissolution DNP MR. From recent results on acetate transport in the rat brain reporting Michaelis-Menten parameters, V max B1 mmol/g/min and K M ¼ B4 mmol/L in the study by Deelchand et al 9 or V max B1.3 mmol/g/min and K M ¼ B27 mmol/L in the study by Patel et al, 10 we can estimate that the acetate concentration 20 seconds after the injection is on the order of 0.28 or 0.19 mmol/g, respectively. The average ratio of 2.2±0.3 between the [1-13 C]acetate and [5-13 C]2OG signal integrals measured in the present study ( Figure 3 ) thus suggest that the 2OG concentration in the brain is between 0.28/2.2 ¼ 0.125 mmol/g and 0.19/2.2 ¼ 0.085 mmol/g, which is comparable with the values given by Siesjö . 31 In fact, as 2OG participates in at least three distinct mitochondrial reactions, namely, 2OG dehydrogenase , glutamate dehydrogenase, and AAT, it is unlikely that all enzymes can simultaneously bind to 2OG. We further conclude that as the enhanced polarization must be preserved during the four enzymatic steps between acetyl-CoA and 2OG (Figure 4 ), all other TCA cycle intermediates, in particular glial citrate, are present at either a much lower concentration than 2OG or in a predominantly bound state.
The 13 C label transfer from mitochondrial TCA cycle intermediate to cytosolic amino acid, in particular Glu, is mediated at least in part by the malate-aspartate shuttle thought to operate at the rate of mitochondrial AAT. 7 Assuming rapid mitochondrial AAT action in astrocytes, one would expect to observe a significant Glu signal. Indeed, assuming a glial Glu concentration ofB1 mmol/g and taking a reported transamination rate ofB50 mmol/g/min, 7 the turnover time of Glu should be on the order of 1 seconds, which is significantly shorter than the [1-13 C]Glu T 1 (B17 seconds in perfused heart). 32 It has, however, been suggested that the Gluaspartate antiporter, known to be rate-limiting for malateaspartate shuttle, may operate at much lower rates, close to those of the TCA cycle. 5 The absence of Glu signal indeed indicates a slow exchange of label between 2OG and Glu, whether mediated by AAT alone or malate-aspartate shuttle. Assuming a linear fractional enrichment of 2OG from 0% to 100% within the 20 seconds of the experiment, we deduced that the maximum concentration of [5-13 C] Glu after 20 seconds is given by the integration over time of t/20 Á V x mmol/g between t ¼ 0 and t ¼ 20 seconds, where V x is the transmitochondrial label exchange (the dilution of 2OG by the Glu pool is not taken into account).
Taking V x ¼ 0.17±0.01 mmol/g/min, 33 we deduce that the [5] [6] [7] [8] [9] [10] [11] [12] [13] C]Glu concentration should be at most 0.028±0.003 mmol/g, which seems to be below our detection level as no significant Glu signal could be observed even after averaging the signals ( Figures  1B, 2C and 2D ). The fact that citrate was not observed implies that the glial citrate concentration is very low or too broad to be detected. It is of interest to note that recent studies have suggested a very low expression of the Glu-aspartate antiporter in astrocytes. 34 We conclude from the novel observation of 2OG signal and the lack of Glu signal that the reactions leading to 13 C-label incorporation into Glu are operating, in the glial compartment in vivo, at a rate much lower than that of transaminase, thus implying that transport across the inner mitochondria membrane is rate limiting. More generally, the present study illustrates the potential of hyperpolarized acetate as a precursor to noninvasively directly probe glial TCA cycle activity and thus detect pathological alterations hitherto inaccessible to direct observation. The direct determination of TCA cycle intermediates bears the potential to determine TCA cycle rate without the need to assess the conversion and transport of 2OG to glutamate. Several previous in vivo studies showed that the hyperpolarized state of 13 C-labels survives metabolic reactions. [35] [36] [37] [38] Here, we note that the 13 C polarization is still largely enhanced after as many as four enzymatic reaction steps. Marjań ska et al 39 did not observe 2OG in the rat brain after the injection of hyperpolarized [2-13 C]pyruvate, which may be because of the additional reactions implicated, for example, flux through pyruvate dehydrogenase, or to slow transport.
These results show the feasibility of probing the real-time kinetics of the transformation of a fuel into a TCA cycle intermediate in vivo in the brain. Recent progress showed that the ability of probing real-time metabolism in vivo could become crucial in cancer research. 35, 38 In the context of the present study, it is of particular interest to note that a large fraction of gliomas, the most common brain tumor type in humans, are associated with genetic mutations in the isocitrate dehydrogenase enzyme affecting the metabolism of isocitrate and giving the enzyme the ability to produce 2-hydroxyglutarate. 40, 41 As the metabolic flux from acetate to 2OG should be affected by variations in the conversion rate between isocitrate and 2OG, the new hyperpolarized MR protocol presented in this report could potentially be used to detect in vivo effect of the mutations on the metabolic rates. In addition, as a dramatic reduction of the isocitrate dehydrogenase as well as 2OG dehydrogenase activities were observed in numerous brain disorders, 42 in particular in Alzheimer's disease patients, 43 the ability to measure the 13 C labeling of the 2OG pool in real time could give this metabolite the status of a sensitive biomarker for neurological dysfunctions.
